Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, 37 Guo Xue Road, Chengdu, 610041, Sichuan Province, China.
Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Surg Endosc. 2019 Apr;33(4):1155-1166. doi: 10.1007/s00464-018-6380-0. Epub 2018 Aug 17.
Few studies had been performed to concern the outcomes of pure laparoscopic Glissonian pedicle approach hepatectomy (LGAH) for hepatocellular carcinoma (HCC). The aim of this study was to compare the outcomes of LGAH versus open Glissonian pedicle approach hepatectomy (OGAH) for HCC, especially in patients with cirrhosis.
Hepatocellular carcinoma patients who underwent pure LGAH and OGAH between January 2015 and July 2017 in our institution were retrospectively enrolled in this study. Propensity score matching (PSM) of patients in a ratio of 1:1 was conducted to adjust the known confounders. The perioperative and oncological outcomes were compared between the two groups after PSM.
Some 80 patients underwent pure LGAH and 134 had OGAH. After PSM, 67 patients in each group were well matched for analysis. Both the postoperative overall complication rates (13.4% vs. 29.9%, P = 0.021) and mean comprehensive complication index (2.63 vs. 7.40, P = 0.035) were significantly lower in the LGAH group than those in OGAH group. Although the operative time was longer in the LRH group (P < 0.001), the length of postoperative hospital stay was shorter in the LRH group (P = 0.024). Furthermore, both the 3-year overall survival rate (73.3% for LGAH vs. 77.8% for OGAH, P = 0.338) and 3-year disease-free survival rate (56.4% for LGAH vs. 62.5% for OGAH, P = 0.455) were not significantly different between the groups.
Pure laparoscopic Glissonian approach may be a better alternative to open Glissonian approach in selected HCC patients, which provided fewer complications, shorter postoperative hospital stay and comparable oncological outcomes.
目前,仅有少数研究关注单纯腹腔镜下 Glisson 蒂 approach 肝切除术(LGAH)治疗肝细胞癌(HCC)的疗效。本研究旨在比较 LGAH 与开腹 Glisson 蒂 approach 肝切除术(OGAH)治疗 HCC 的疗效,尤其在肝硬化患者中的疗效。
回顾性分析 2015 年 1 月至 2017 年 7 月我院收治的行单纯 LGAH 和 OGAH 的 HCC 患者。采用 1:1 倾向评分匹配(PSM)对患者进行匹配,以调整已知混杂因素。PSM 后比较两组患者的围手术期和肿瘤学结果。
80 例行单纯 LGAH,134 例行 OGAH。PSM 后,每组各有 67 例患者进行分析。LGAH 组的总术后并发症发生率(13.4%比 29.9%,P=0.021)和平均综合并发症指数(2.63 比 7.40,P=0.035)均显著低于 OGAH 组。虽然 LGAH 组的手术时间较长(P<0.001),但术后住院时间较短(P=0.024)。此外,LGAH 组的 3 年总生存率(73.3%比 77.8%,P=0.338)和 3 年无病生存率(56.4%比 62.5%,P=0.455)均无显著差异。
在选择合适的 HCC 患者中,单纯腹腔镜下 Glisson 蒂 approach 可能是开腹 approach 的更好选择,可减少并发症,缩短术后住院时间,且具有相似的肿瘤学疗效。